UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider services overcame rising costs and a cyberattack.

UnitedHealth Group CEO Andrew Witty told analysts that the company is positioned well for growth in 2025. This comes just a month after the CEO of its insurance unit was murdered.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

UnitedHealth shares tumbled Thursday after the health insurer reported fourth-quarter results below Wall Street’s expectations and issued a lackluster outlook. Monitor these key post-earnings price levels.

UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing of UnitedHealthcare CEO Brian Thompson in New York City, which sparked a wider debate about the cost of health insurance and medication for the American public.

Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In 2024, the US economy was stronger than expected;

UnitedHealth Group shares fell Thursday after the company reported fourth-quarter results that missed analysts' expectations.

UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization surprised Wall Street.

UnitedHealth Group (UNH) , the largest health insurance provider in the U.S., ended 2024 on a devastating note. The company, which owns UnitedHealthcare and Optum, has been embroiled in massive controversy after UnitedHealthcare CEO Brian Thompson was shot and killed in front of a Hilton hotel in midtown Manhattan last month.

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was overcharging cancer patients by 1000%.

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their pharmacies through network exclusions and targeted marketing.